Cargando…

Outcomes of diuretics in rheumatic heart disease with compensated chronic heart failure: a retrospective study

AIMS: The purpose of this retrospective propensity score‐matched study was to evaluate the superiority of different application approaches [continuous diuretics use (CDU) vs. intermittent diuretics use (IDU)] and types [loop diuretics (LDs) vs. thiazide diuretics (TDs)] of diuretics on long‐term out...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Cheng, Lai, Yanxian, Guan, Tianwang, Shen, Yan, Pan, Yichao, Wu, Deping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754903/ https://www.ncbi.nlm.nih.gov/pubmed/32945144 http://dx.doi.org/10.1002/ehf2.12987

Ejemplares similares

Association of Digoxin Application Approaches With Long-Term Clinical Outcomes in Rheumatic Heart Disease Patients With Heart Failure: A Retrospective Study
por: Liu, Cheng, et al.
Publicado: (2021)

Impact of renin‐angiotensin system inhibitors on long‐term clinical outcomes of patients with rheumatic heart disease
por: Liu, Cheng, et al.
Publicado: (2021)

Different heart failure phenotypes of valvular heart disease: the role of mitochondrial dysfunction
por: Zhang, Shenghui, et al.
Publicado: (2023)

Diuretic Resistance in Heart Failure
por: Gupta, Richa, et al.
Publicado: (2019)

Diuretics in the management of chronic heart failure: when and how
por: Magdy, Joseph S, et al.
Publicado: (2022)

Diuretics as pathogenetic treatment for heart failure
por: Guglin, Maya
Publicado: (2011)

Optimal diuretic strategies in heart failure
por: Suri, Sarabjeet S., et al.
Publicado: (2021)

Diuretic Resistance Associated With Heart Failure
por: Shams, Elham, et al.
Publicado: (2022)

Role of Diuretics and Ultrafiltration in Congestive Heart Failure
por: Shchekochikhin, Dmitry, et al.
Publicado: (2013)

The Diuretic Effect of Theocalcin in Congestive Heart Failure
Publicado: (1931)

Use of loop diuretics in patients with chronic heart failure: an observational overview
por: Scholte, Niels TB, et al.
Publicado: (2023)

Decongestion: Diuretics and other therapies for hospitalized heart failure
por: Vazir, Ali, et al.
Publicado: (2016)

Tolvaptan: A Novel Diuretic in Heart Failure Management
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016)

Diuretic dosing in heart failure: more data are needed
por: De Vecchis, Renato, et al.
Publicado: (2018)

Combined aquaretic and diuretic therapy in acute heart failure
por: Goyfman, Michael, et al.
Publicado: (2017)

Congestion and Diuretic Resistance in Acute or Worsening Heart Failure
por: Kristjánsdóttir, Ingibjörg, et al.
Publicado: (2020)

The Importance of the Nephrologist in the Treatment of the Diuretic-Resistant Heart Failure
por: Pethő, Ákos Géza, et al.
Publicado: (2023)

Association between changes in loop diuretic dose and outcomes in acute heart failure
por: Seko, Yuta, et al.
Publicado: (2023)

Impact of chronic kidney disease on the diuretic response of tolvaptan in acute decompensated heart failure
por: Ikeda, Shuntaro, et al.
Publicado: (2017)

Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study
por: Imiela, Tomasz, et al.
Publicado: (2017)

Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic Syndrome
por: Qavi, Ahmed Hassaan, et al.
Publicado: (2015)

Effects of Empagliflozin on Diuretics Reduction in Outpatient Heart Failure Patients
por: Kim, Soo-Jin, et al.
Publicado: (2022)

Toward quantification of loop diuretic responsiveness for congestive heart failure
por: Oyama, Mark A., et al.
Publicado: (2022)

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics
por: Yeoh, Su Ern, et al.
Publicado: (2023)

Evaluation of diuretic efficiency of intravenous furosemide in patients with advanced heart failure in a heart failure clinic
por: Herrera-Leaño, Nancy, et al.
Publicado: (2023)

Trial of Oral Diuretics Prior to Discharge Is Not Associated With Improved Outcomes in Decompensated Heart Failure
por: Mohammad, Adeba, et al.
Publicado: (2021)

A retrospective study of 14 dogs with advanced heart failure treated with loop diuretics and hydrochlorothiazide
por: Iwanaga, Koji, et al.
Publicado: (2021)

Genetic predisposition and bioinformatics analysis of ATP-sensitive potassium channels polymorphisms with the risks of elevated apolipoprotein B serum levels and its related arteriosclerosis cardiovascular disease
por: Liu, Cheng, et al.
Publicado: (2021)

Loop Diuretic Administration in Patients with Acute Heart Failure and Reduced Systolic Function: Effects of Different Intravenous Diuretic Doses and Diuretic Response Measurements
por: Ruocco, Gaetano, et al.
Publicado: (2019)

Diuretic Resistance Prediction and Risk Factor Analysis of Patients with Heart Failure During Hospitalization
por: Lu, Xiao, et al.
Publicado: (2022)

Discontinuation of Loop Diuretics in Older Patients with Chronic Stable Heart Failure: A Narrative Review
por: Okoye, Chukwuma, et al.
Publicado: (2023)

Loop diuretics in acute heart failure: beyond the decongestive relief for the kidney
por: Palazzuoli, Alberto, et al.
Publicado: (2015)

Markers of diuretic resistance in emergency department patients with acute heart failure
por: Doering, Andrew, et al.
Publicado: (2017)

Worsening renal function in acute heart failure in the context of diuretic response
por: Emmens, Johanna E., et al.
Publicado: (2021)

Empagliflozin Administration Can Decrease the Dose of Loop Diuretics and Prevent the Exacerbation of Renal Tubular Injury in Patients With Compensated Heart Failure Complicated by Diabetes
por: Shirakabe, Akihiro, et al.
Publicado: (2020)

ATP-sensitive potassium channels gene polymorphism rs1799858 affects the risk of macro-/micro-vascular arteriosclerotic event in patients with increased low-density lipoprotein cholesterol levels
por: Liu, Cheng, et al.
Publicado: (2020)

Effect of diuretic infusion clinic in preventing hospitalization for patients with decompensating heart failure
por: Alghalayini, Kamal Waheeb
Publicado: (2020)

Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure
por: Yoshioka, Kenji, et al.
Publicado: (2022)

Spot Urinary Sodium as a Biomarker of Diuretic Response in Acute Heart Failure
por: Oliva‐Damaso, Nestor, et al.
Publicado: (2023)

The Potential Role of Torsemide in Optimizing Loop Diuretic Therapy for Heart Failure Patients
por: Chopra, V. K, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9s15suu5i1amqlalgp8m8fvj71